// App-Quantinova.ai

1036 : Cellular phenotypes of a novel series of 3-phosphoglycerate dehydrogenase inhibitors

Researchers

Presenter

  • Nello Mainolfi

Principal Investigators

  • Adam Friedman

  • Mikel P. Moyer

  • Vipin Suri

  • Mark Manfredi

Medical Centers

  • Jounce Therapeutics, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • Phosphoglycerate Dehydrogenase

Drug/Treatment

  • Nicotinamide

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved